Kinetic target-guided synthesis represents an efficient hit-identification strategy,i nw hich the protein assembles its own inhibitors from ap oolo fc omplementary building blocks via an irreversible reaction. Herein, we pioneered an in situ Ugi reactionf or the identification of novel inhibitors of am odel enzyme and binders for an important drug target, namely,t he aspartic protease endothiapepsina nd the bacterial b-sliding clamp DnaN, respectively.H ighly sensitive mass-spectrometry methods enabledm onitoring of the protein-templated reaction of four complementaryr eaction partners, which occurredi nabackground-free manner for endothiapepsin or with ac lear amplification of two binders in the presence of DnaN. TheU gi products we identified show low micromolar activity on endothiapepsin or moderate affinity for the b-sliding clamp. We succeeded in expanding the portfolioo fc hemical reactions and biological targets and demonstrated the efficiency and sensitivity of this approach,which can find application on any drug target.